Loading...
•
Jul 31, 2024
HealthEquity Q2 2025 Earnings Report
HealthEquity's Q2 2025 financial results were released, showcasing revenue growth and increased profitability.
Key Takeaways
HealthEquity reported strong second-quarter results, with a 23% increase in revenue to $299.9 million and a significant rise in net income to $35.8 million. The company also announced a $300 million stock repurchase program.
Revenue increased by 23% year-over-year, reaching $299.9 million.
Net income rose to $35.8 million, a substantial increase from $10.6 million in the same quarter last year.
Non-GAAP net income increased by 67% to $76.3 million.
The company reported 9.4 million HSAs, a 15% increase compared to the previous year.
Revenue by Segment
Forward Guidance
For the fiscal year ending January 31, 2025, HealthEquity expects revenue between $1.165 billion and $1.185 billion, net income between $94 million and $109 million, and Adjusted EBITDA between $458 million and $478 million.
Positive Outlook
- Revenue is expected to be between $1.165 billion and $1.185 billion.
- Net income is projected to be between $94 million and $109 million.
- Net income per diluted share is expected to be between $1.05 and $1.22.
- Non-GAAP net income is forecasted to be between $265 million and $280 million.
- Adjusted EBITDA is anticipated to be between $458 million and $478 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...